StockData
Q/C Technologies, Inc. logo

Q/C Technologies, Inc. (QCLS) stock

QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.33+0.01 (+4.05%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

Q/C Technologies ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Q/C Technologies's ebitda for the twelve months ending Dec 31, 2020 was -$9.46M. For fiscal 2020 it was -$9.46M. The highest annual figure on record is -$1.46M in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$9.46M–
FY2019Dec 31, 2019-$3.40M–
FY2018Dec 31, 2018-$9.83M–
FY2017Dec 31, 2017-$6.36M–
FY2016Dec 31, 2016-$3.04M–
FY2015Dec 31, 2015-$9.38M–
FY2014Dec 31, 2014-$2.85M–
FY2013Dec 31, 2013-$1.46M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020-$4.17M–
Q3 FY2020Sep 30, 2020-$3.24M–
Q2 FY2020Jun 30, 2020-$1.08M–
Q1 FY2020Mar 31, 2020-$3.53M–
Q4 FY2019Dec 31, 2019-$671.13K–
Q3 FY2019Sep 30, 2019-$836.22K–
Q2 FY2019Jun 30, 2019-$802.17K–
Q1 FY2019Mar 31, 2019-$924.57K–
Q4 FY2018Dec 31, 2018-$2.87M–
Q3 FY2018Sep 30, 2018-$3.06M–
Q2 FY2018Jun 30, 2018-$2.06M–
Q1 FY2018Mar 31, 2018-$1.84M-548.8%
Q2 FY2017Jun 30, 2017-$760.00K–
Q1 FY2017Mar 31, 2017-$1.30M–
Q4 FY2016Dec 31, 2016-$1.03M–
Q3 FY2016Sep 30, 2016$409.30K–
Q2 FY2016Jun 30, 2016-$957.38K–
Q1 FY2016Mar 31, 2016-$1.46M–

More Q/C Technologies figures

See a number that looks wrong?